Step 1
Draft
Step 2
Unite with Fellow Investors
Step 3
Choose the Best Attorney
Step 4
Provide Documents
Step 5
Follow Case Progress
Step 6
Get Payout
OVAS.US
id: 277
The settlement funds have been distributed to claimants.
$15,000,000
Cash SettlementD. Massachusetts
Court1:17-cv-10511
Case number12/17/2014
Class period Start09/28/2015
Class period End02/22/2022
Claim deadlineDahhan v. OvaScience, Inc., et al.
"Among other things, the Complaint alleges that, during the Class Period, the OvaScience Defendants knowingly or recklessly misrepresented and concealed material facts regarding the efficacy and commercial viability of AUGMENT. More specifically, the Complaint alleges that throughout the Class Period, the OvaScience Defendants made numerous public statements that led investors to believe that AUGMENT worked, and that there was significant demand from patients, which caused OvaScience’s common stock to allegedly trade at artificially inflated prices during the Class Period. The Complaint further alleges that the price of OvaScience stock declined when the true facts concerning the OvaScience Defendants’ alleged misrepresentations and omissions were revealed, resulting in financial losses to those who purchased or acquired OvaScience common stock during the Class Period at the inflated prices."
Case Type
US Securities Class Action
Case Status
Disbursed
Alleged Offence
Other
Suspected Party
Other
Security Type
Stocks
Trade Direction
Long
Plaintiffs
Reedman Family Investments LLC
Attorneys
Robbins Geller Rudman & Dowd LLP
Judge
Hon. Indira Talwani
Administrator
Gilardi & Co LLC
Court hearing date
07/26/2022
Trades matching type
FIFO
Disbursement date
03/17/2025
Trusted by industry leaders
Endorsed by top professionals who trust our innovative solutions to drive impactful results.